Table 2. Serum APE1/Ref-1 and clinical outcomes.
Total (n=354) | Angina (n=128) | MI (n=175) | p | |
---|---|---|---|---|
Total | 35 (9.9) | 12 (9.4) | 23 (13.1) | |
Death | 26 (7.3) | 8 (6.3) | 18 (10.3) | |
Recurrent MI | 0 (0.0) | 0 (0.0) | 0 (0.0) | Not significant |
Stroke | 1 (0.3) | 0 (0.0) | 1 (0.6) | |
Revascularization | 8 (2.3) | 4 (3.1) | 4 (2.3) |
Data are expressed as n (%). APE1/Ref-1: apurinic/apyrimidinic endonuclease 1/redox effector factor 1, MI: myocardial infarction